Bio Solution Co Ltd (086820)

Currency in KRW
7,930
+140(+1.80%)
Closed·
086820 Scorecard
Full Analysis
RSI suggests the stock is in oversold territory
Earnings results expected in 15 days
Fair Value
Day's Range
7,7808,060
52 wk Range
7,70036,750
Key Statistics
Bid/Ask
7,920.00 / 7,930.00
Prev. Close
7,790
Open
8,060
Day's Range
7,780-8,060
52 wk Range
7,700-36,750
Volume
36.29K
Average Volume (3m)
170.9K
1-Year Change
-42.42%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
086820 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Sell

Bio Solution Co Ltd Company Profile

Bio Solution Co.,Ltd. develops, manufactures, and sells cell therapy products worldwide. The company offers CartiLife, an autologous chondrocyte cell-based therapy for the restoration of symptomatic and structural complications caused by articular cartilage defects; KeraHeal-Allo, a thermosensitive hydrogel-type allogenic keratinocyte cell-therapy product to promote re-epithelialization of deep 2nd-degree burn wounds; and KeraHeal, an autologous spray-type keratinocyte cell-based therapy for skin wounds. It also provides reconstructed human micro-tissue models comprising KeraSkin, an epidermis model; KeraSkin-FT, a full-thickness skin model; KeraSkin-M, a pigmented skin model; corneal models; SoluAirway, a airway mucosa model; SoluOral, an oral mucosa model; SoluDPNeuron, a dopaminergic neuron model; SoluDANeuron, an islet model; and SoluLiver, a liver model. In addition, the company provides human-derived primary cell cultures and primary cells for in vitro research; bio advanced materials; and cosmetics raw materials. The company was formerly known as MCTT Bio Co., Ltd. and changed its name to Bio Solution Co.,Ltd. in January 2016. Bio Solution Co.,Ltd. was founded in 2000 and is headquartered in Seoul, South Korea.

Employees
71

Compare 086820 to Peers and Sector

Metrics to compare
086820
Peers
Sector
Relationship
P/E Ratio
0.0x−4.4x−0.5x
PEG Ratio
0.00−0.090.00
Price/Book
0.0x2.1x2.6x
Price / LTM Sales
0.0x18.6x3.3x
Upside (Analyst Target)
0.0%30.8%45.1%
Fair Value Upside
Unlock3.6%7.4%Unlock

Earnings

Latest Release
May 19, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

086820 Income Statement

FAQ

What Stock Exchange Does Bio Solution Trade On?

Bio Solution is listed and trades on the KOSDAQ stock exchange.

What Is the Stock Symbol for Bio Solution?

The stock symbol for Bio Solution is "086820."

What Is the Bio Solution Market Cap?

As of today, Bio Solution market cap is 186.11B.

What Is Bio Solution's Earnings Per Share (TTM)?

The Bio Solution EPS (TTM) is -53.63.

When Is the Next Bio Solution Earnings Date?

Bio Solution will release its next earnings report on 18 Aug 2025.

From a Technical Analysis Perspective, Is 086820 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Bio Solution Stock Split?

Bio Solution has split 1 times.

How Many Employees Does Bio Solution Have?

Bio Solution has 71 employees.

What is the current trading status of Bio Solution (086820)?

As of 04 Aug 2025, Bio Solution (086820) is trading at a price of 7,930.00, with a previous close of 7,790.00. The stock has fluctuated within a day range of 7,780.00 to 8,060.00, while its 52-week range spans from 7,700.00 to 36,750.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.